Document is current
Any future updates will be listed below
-
Authors
,
Keppens, Cleo https://orcid.org/0000-0002-4498-8386
Dequeker, Elisabeth M. C.
Patton, Simon J.
Normanno, Nicola
Fenizia, Francesca
Butler, Rachel
Cheetham, Melanie
Fairley, Jennifer A.
Williams, Hannah
Hall, Jacqueline A.
Schuuring, Ed
Deans, Zandra C.
-
Funding
Funding for this research was provided by:
Amgen, AstraZeneca, Boehringer Ingelheim, Biocartis, Horizon Diagnostics, Merck KGaA, Qiagen, Roche, Sysmex Inostics, Seracare and Thermo Fisher Scientific/Life Technologies
- License Information
-
More Information
Article History
Received: 12 January 2018
Accepted: 25 July 2018
First Online: 9 August 2018
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: EMCD received research grants from Pfizer and Amgen. SJP received financial support for educational programmes from Astra Zeneca. NN received fees or research funds from Roche, Qiagen, Thermofisher, Merck, and Astrazeneca. JAH owns stock in Vivactiv Ltd. ES performed lectures for Illumina, Novartis, Pfizer, BioCartis; is consultant in advisory boards for AstraZeneca, Pfizer, Novartis, BioCartis; and received financial support from Roche, Biocartis, BMS, Pfizer (all fees to the Institution). ZCD received financial support for educational programmes from Astra Zeneca, Roche and Qiagen and is a member of advisory boards for Amgen, Astra Zeneca, Pfizer, Merck Serono and Roche. All other authors have nothing to declare.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
